Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Heine

Showing results (1-10 of 163) with videos related to

Pageof 17
Sort By:
Current Diabetes Reports|March 9, 2006
The role of postprandial hyperglycemia and hyperlipidemia in CVD riskRobert J Heine
Diabetes, Obesity & Metabolism|September 2, 2005
Unlocking the opportunity of tight glycaemic control. Promise ahead: the role of inhaled insulin in clinical practiceRobert J Heine
The New England Journal of Medicine|July 27, 2007
Diabetic gastroparesisRobert J Heine, Robert Brodows
Drugs|June 27, 2003
Thiazolidinediones in type 2 diabetes mellitus: current clinical evidenceMichaela Diamant, Robert J Heine
Diabetes Care|July 29, 2003
Insulin pump therapy: a meta-analysis: response to Weissberg-Benchell et alJ Hans DeVries, Robert J Heine
BMJ (Clinical Research Ed.)|July 6, 2002
Insulin pumps are still debatable for type 1 diabetesJ Hans DeVries, Robert J Heine
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|February 19, 2026
Perceived Diabetes Burden, Clinical Care Gap, and Intent to Prescribe a Diabetes Polypill to Indian Patients with Type 2 DiabetesRobert J Heine, Indranil Bhattacharya, Maithri Singh
Current Diabetes Reports|June 6, 2007
Nonalcoholic fatty liver disease and cardiovascular disease riskRoger K Schindhelm, Michaela Diamant, Robert J Heine
Diabetes Care|December 25, 2003
Non-HDL cholesterol contributes to the "hypertriglyceridemic waist" as a cardiovascular risk factor: the Hoorn studyGriët Bos, Jacqueline M Dekker, Robert J Heine, et al.
Diabetes Care|August 30, 2007
Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patientsRoger K Schindhelm, Robert J Heine, Michaela Diamant
Pageof 17

Showing results (1-10 of 163) with videos related to

Sort By:
Pageof 17
Current Diabetes Reports|March 9, 2006
The role of postprandial hyperglycemia and hyperlipidemia in CVD riskRobert J Heine
Diabetes, Obesity & Metabolism|September 2, 2005
Unlocking the opportunity of tight glycaemic control. Promise ahead: the role of inhaled insulin in clinical practiceRobert J Heine
The New England Journal of Medicine|July 27, 2007
Diabetic gastroparesisRobert J Heine, Robert Brodows
Drugs|June 27, 2003
Thiazolidinediones in type 2 diabetes mellitus: current clinical evidenceMichaela Diamant, Robert J Heine
Diabetes Care|July 29, 2003
Insulin pump therapy: a meta-analysis: response to Weissberg-Benchell et alJ Hans DeVries, Robert J Heine
BMJ (Clinical Research Ed.)|July 6, 2002
Insulin pumps are still debatable for type 1 diabetesJ Hans DeVries, Robert J Heine
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|February 19, 2026
Perceived Diabetes Burden, Clinical Care Gap, and Intent to Prescribe a Diabetes Polypill to Indian Patients with Type 2 DiabetesRobert J Heine, Indranil Bhattacharya, Maithri Singh
Current Diabetes Reports|June 6, 2007
Nonalcoholic fatty liver disease and cardiovascular disease riskRoger K Schindhelm, Michaela Diamant, Robert J Heine
Diabetes Care|December 25, 2003
Non-HDL cholesterol contributes to the "hypertriglyceridemic waist" as a cardiovascular risk factor: the Hoorn studyGriët Bos, Jacqueline M Dekker, Robert J Heine, et al.
Diabetes Care|August 30, 2007
Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patientsRoger K Schindhelm, Robert J Heine, Michaela Diamant
Pageof 17